Literature DB >> 5256215

Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens.

I Hellström, K E Hellström, C A Evans, G H Heppner, G E Pierce, J P Yang.   

Abstract

The combined effect of immune lymphocytes (lymphnode cells or blood lymphocytes) and serum from tumor-bearing donors was assessed in four tumor systems with the use of the colony inhibition assay: (a) Moloney virus-induced sarcomas in mice, (b) Shope papillomas in rabbits, (c) spontaneous mammary carcinomas in mice, and (d) two adenocarcinomas of the colon and two adenocarcinomas of the lung in humans. The neoplasms studied had previously been shown to possess tumor-specific antigens, against which cellular immunity could be detected in vitro. In all four systems, it was found that sera from hosts with progressively growing neoplasms could abrogate the inhibitory effect of lymphocytes which were immune to the specific antigens of the corresponding tumor type. Studies with Moloney sarcomas, in particular, showed that the serum effect had at least some degree of specificity.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5256215      PMCID: PMC277801          DOI: 10.1073/pnas.62.2.362

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Antigenicity of a virus-induced murine sarcoma (Moloney).

Authors:  A Fefer; J L McCoy; J P Glynn
Journal:  Cancer Res       Date:  1967-05       Impact factor: 12.701

2.  Demonstration of cell-bound and humoral immunity against neuroblastoma cells.

Authors:  I E Hellström; K E Hellström; G E Pierce; A H Bill
Journal:  Proc Natl Acad Sci U S A       Date:  1968-08       Impact factor: 11.205

3.  Immunologic, virologic, and pathologic studies of regression of autochthonous Moloney sarcoma virus-induced tumors in mice.

Authors:  A Fefer; J L McCoy; K Perk; J P Glynn
Journal:  Cancer Res       Date:  1968-08       Impact factor: 12.701

4.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

5.  The use of enhancement in studying tumor antigens.

Authors:  J R Batchelor
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

6.  In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs.

Authors:  I Hellström; K E Hellström; G E Pierce
Journal:  Int J Cancer       Date:  1968-07-15       Impact factor: 7.396

7.  Heterogeneity in biologic functions of antibodies: implications for immunologic tumor enhancement.

Authors:  K J Bloch
Journal:  Fed Proc       Date:  1965 Sep-Oct

8.  Antitumor immunity in the Shope papilloma-carcinoma complex of rabbits. 3. Response to reinfection with viral nucleic acid.

Authors:  C A Evans; Y Ito
Journal:  J Natl Cancer Inst       Date:  1966-06       Impact factor: 13.506

9.  Factors influencing the induction of enhancement and resistance to methylcholanthrene-induced tumours in a syngenic system.

Authors:  J Bubeník; P Koldovský
Journal:  Folia Biol (Praha)       Date:  1965       Impact factor: 0.906

10.  Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro.

Authors:  L J Old; E Stockert; E A Boyse; J H Kim
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  43 in total

1.  Lymphocyte responsiveness to phytohemagglutinin (PHA) and serum inhibitory effect in patients with gastric cancer.

Authors:  T Toge; H Ikeda; N Senoo; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1976-12

2.  Lymphocytotoxicity to tumor target cells and interference of serum factors or tumor antigen with lymphocytotoxicity in patients suffering from different stages of breast carcinoma.

Authors:  H Warnatz; D Lackner; E Eder; F Scheiffarth; M Gruhl; O Bischoff
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-02-25

3.  A study of lymph nodes draining colorectal cancer using a two-stage inhibition of leucocyte migration technique.

Authors:  P J Guillou; T G Brennan; G R Giles
Journal:  Gut       Date:  1975-04       Impact factor: 23.059

4.  Cell-mediated immunity (CMI) to human wart virus and wart-associated tissue antigens.

Authors:  A K Lee; M Eisinger
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

5.  Antibodies sequestered in the liver granulomata of 8-week infections of CF1 mice by Schistosoma mansoni Sambon, 1907.

Authors:  F Sogandares-Bernal; S Brandt
Journal:  Z Parasitenkd       Date:  1976-10-12

6.  Cell line derived from a murine sarcoma virus (Moloney Pseudotype)-induced tumor: cultural, antigenic, and virological properties.

Authors:  J G Massicot; W A Woods; M A Chirigos
Journal:  Appl Microbiol       Date:  1971-12

Review 7.  Tumour-associated antigens and tumour-host interactions.

Authors:  R W Baldwin
Journal:  Proc R Soc Med       Date:  1971-10

8.  Tumour development following immunosuppression.

Authors:  A C Allison
Journal:  Proc R Soc Med       Date:  1970-10

9.  Are observations on tumour viruses in animals applicable to man?

Authors:  A C Allison
Journal:  Proc R Soc Med       Date:  1970-04

10.  Circulating immune complexes in sera of children with neuroblastoma: correlation with stage of disease.

Authors:  W E Brandeis; L Helson; Y Wang; R A Good; N K Day
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.